ADMINISTRATIVE CORE - CORE A: ABSTRACT The BIOCARD study is a longitudinal, observational study of 349 individuals who were cognitively normal and primarily middle aged (mean age=57.1) at enrollment. Our overall objectives are to further advance the study of preclinical AD by: (1) clarifying the pattern and rate of changes in AD biomarkers (including CSF, MRI, amyloid imaging and blood) and cognition that occur during the earliest phases of AD, (2) maximizing our data by working collaboratively with several research groups who have comparable data, and (3) providing a publicly accessible database, to include biological specimens, for researchers in the field. To accomplish these goals we established 7 Cores. The Administrative Core (Core A) is essential for the overall functioning and coordination of the project.
The specific aims i nclude: (1) oversight and integration of the Cores in the project, (2) facilitation of collaborative research with investigators outside of Johns Hopkins University (JHU), (3) assurance of sound fiscal management, (4) assurance that all aspects of the project comply with local and federal regulations, (5) coordinating external review of the project through meetings of the Scientific Advisory Board and the Resource Allocation Committee, and (6) communicating with the staff of the National Institute on Aging (NIA) consistent with the guidelines of the FOA.
|Sacktor, Ned; Soldan, Anja; Grega, Maura et al. (2017) The BIOCARD Index: A Summary Measure to Predict Onset of Mild Cognitive Impairment. Alzheimer Dis Assoc Disord 31:114-119|
|Pettigrew, Corinne; Soldan, Anja; Sloane, Kelly et al. (2017) Progressive medial temporal lobe atrophy during preclinical Alzheimer's disease. Neuroimage Clin 16:439-446|
|Tward, Daniel; Miller, Michael; Trouve, Alain et al. (2017) Parametric Surface Diffeomorphometry for Low Dimensional Embeddings of Dense Segmentations and Imagery. IEEE Trans Pattern Anal Mach Intell 39:1195-1208|
|Gross, Alden L; Hassenstab, Jason J; Johnson, Sterling C et al. (2017) A classification algorithm for predicting progression from normal cognition to mild cognitive impairment across five cohorts: The preclinical AD consortium. Alzheimers Dement (Amst) 8:147-155|
|Cai, Qing; Wang, Mei-Cheng; Chan, Kwun Chuen Gary (2017) Joint modeling of longitudinal, recurrent events and failure time data for survivor's population. Biometrics 73:1150-1160|
|Varma, V R; Varma, S; An, Y et al. (2017) Alpha-2 macroglobulin in Alzheimer's disease: a marker of neuronal injury through the RCAN1 pathway. Mol Psychiatry 22:13-23|
|Pettigrew, Corinne; Soldan, Anja; Zhu, Yuxin et al. (2017) Cognitive reserve and cortical thickness in preclinical Alzheimer's disease. Brain Imaging Behav 11:357-367|
|Mori, Susumu; Kageyama, Yusuke; Hou, Zhipeng et al. (2017) Elucidation of White Matter Tracts of the Human Amygdala by Detailed Comparison between High-Resolution Postmortem Magnetic Resonance Imaging and Histology. Front Neuroanat 11:16|
|Soldan, Anja; Pettigrew, Corinne; Cai, Qing et al. (2017) Cognitive reserve and long-term change in cognition in aging and preclinical Alzheimer's disease. Neurobiol Aging 60:164-172|
|Leoutsakos, J-M; Gross, A L; Jones, R N et al. (2016) 'Alzheimer's Progression Score': Development of a Biomarker Summary Outcome for AD Prevention Trials. J Prev Alzheimers Dis 3:229-235|
Showing the most recent 10 out of 42 publications